Red/Blue

Quote







This is not working. Senior Reps are spread too thin with too heavy of a work level. There was a rumor that CNS would get a new sales team. Has anyone heard the same?
 


anonymous said:
Does anyone know if we will return to Red and Blue? Will there be a change in model in CNS?
Click to expand...

A change in model is coming, Allison mentioned something about it in a town hall. And Mo said not to worry about it the Friday afterwards. Maintena sales were down for a long time probably bc non hospital reps were suddenly selling to hospitals. Rexulti sales could be down because hospital reps don’t care as much about it (that is pure speculation).

Sr HSA model is not working and people are unhappy. Agitation is spread way too thin, covering several territories and LTC plus outpatient accounts. Regular CNS reps are spread too thin and directions from home office are conflicting.

We are due for a re org, but worst case scenario we get fat severance packages and go sell competition drugs. I think it’ll be okay, I’m curious what the meeting on Thursday will be about.
 


anonymous said:
This is not working. Senior Reps are spread too thin with too heavy of a work level. There was a rumor that CNS would get a new sales team. Has anyone heard the same?
Click to expand...
What are you talking about? Spread too thin with so many offices closed forever? If you can't finish your route by Wednesday at the latest you are not working your territory effectively. You bring nothing new to your customers anyways, and "checking samples" is not a call that warrants driving for hours to get nothing accomplished.
 


anonymous said:
A change in model is coming, Allison mentioned something about it in a town hall. And Mo said not to worry about it the Friday afterwards. Maintena sales were down for a long time probably bc non hospital reps were suddenly selling to hospitals. Rexulti sales could be down because hospital reps don’t care as much about it (that is pure speculation).

Sr HSA model is not working and people are unhappy. Agitation is spread way too thin, covering several territories and LTC plus outpatient accounts. Regular CNS reps are spread too thin and directions from home office are conflicting.

We are due for a re org, but worst case scenario we get fat severance packages and go sell competition drugs. I think it’ll be okay, I’m curious what the meeting on Thursday will be about.
Click to expand...
Both drugs are down because of "message fatigue", and the simple fact that our competitors Latuda and Vraylar are better. Nobody wants to listen to the same old story over and over again. The new Rexulti indication causes a "yawn" in most prescribers. And that won't change.
 


Blue/Red whatever you want to call it, here we go again. We wouldn't be in this situation without CEM and BTW CEM is an epic failure! They could have saved money by not screwing with district leadership, umm not having Sra HSA...(dumbest position ever, let's go and promote a bunch of people who have never managed to manage and sell. FYI the Sr HSAs are too busy trying to be managers than working their call plan. Wonder why numbers are dismal? However, to be fair Otsuka trained them a year into the role...WTF! The jury is still out if the manager training worked but whatever. In a nutshell, leadership should have said to collaborate more with your matrix and we will evaluate you on that with an MBO. Most of the CEM Kool-Aid drinkers are gone yet a few remain at the top. I can guarantee they will not be held accountable. Why on earth would you rock a boat that much before two critical launches? Leadership at Otsuka amazes me.
 


anonymous said:
Blue/Red whatever you want to call it, here we go again. We wouldn't be in this situation without CEM and BTW CEM is an epic failure! They could have saved money by not screwing with district leadership, umm not having Sra HSA...(dumbest position ever, let's go and promote a bunch of people who have never managed to manage and sell. FYI the Sr HSAs are too busy trying to be managers than working their call plan. Wonder why numbers are dismal? However, to be fair Otsuka trained them a year into the role...WTF! The jury is still out if the manager training worked but whatever. In a nutshell, leadership should have said to collaborate more with your matrix and we will evaluate you on that with an MBO. Most of the CEM Kool-Aid drinkers are gone yet a few remain at the top. I can guarantee they will not be held accountable. Why on earth would you rock a boat that much before two critical launches? Leadership at Otsuka amazes me.
Click to expand...
Otsuka management lives in a make belief world. Time to take the rose-colored glasses off!
 


anonymous said:
Both drugs are down because of "message fatigue", and the simple fact that our competitors Latuda and Vraylar are better. Nobody wants to listen to the same old story over and over again. The new Rexulti indication causes a "yawn" in most prescribers. And that won't change.
Click to expand...

You are right when you say Latuda and Vraylar are better drugs. Seroquel is better , way better and way cheaper than Rexulti for agitation. Message fatigue is very real. 99% of calls ARE “check samples” and “sign here” calls, oh well, keep those checks coming twice a month!
 


That's the beauty of America... very few get very wealthy at the expense of everybody else, even those who suffer greatly physically and financially. And anyone of authority to challenge or question this practice encounters the lobbyists paid for by big Pharma.

BTW, I am the Uber driver...not a socialist by any means ... more like a Robin Hood.

Now Otsuka, I gotta run, someone needs a ride to his car dealer to pick up his repaired vehicle...
 



Write your reply...
Top Bottom
Back
Quote